106 Results (Page 1 of 9)
Brazil Markets Research Reports
Brazil Diabetes Devices Market Analysis
The Brazil Diabetes Devices Market is expected to witness growth from $568 Mn in 2022 to $1067 Mn in 2030 with a CAGR of 8.20% for the forecasted year 2022-2030. As healthcare expenditures in Brazil increase, a greater focus is being placed on preventive care and the management of chronic diseases. The demand for diabetes management devices, ought to increase as a result. The market is segmented by type and by the end user. Some key players in this market include: Nipro Medical do Brasil Ltda, Arthrocare do Brasil Ltda, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Brazil Cardiac Surgery Instruments Market Analysis
The Brazil Cardiac Surgery Instruments Market is expected to witness growth from $52 Mn in 2022 to $93 Mn in 2030 with a CAGR of 7.60% for the forecasted year 2022-2030. Heart diseases like coronary artery disease and heart failure are very common in Brazil. Due to the rise in cardiac surgeries as a result, there is an increasing need for the tools and instruments used in these operations. The market is segmented by type, application and by end user. Some key players in this market include: Nipro Medical do Brasil Ltda, Arthrocare do Brasil Ltda, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Brazil Cardiovascular Diseases Therapeutics Market Analysis
Brazil's cardiovascular disease therapeutics market is expected to witness growth from $4.06 Bn in 2022 to $7.64 Bn in 2030 with a CAGR of 8.22% for the forecasted year 2022-2030 due to the rising geriatric population and their subsequent demand for new and innovative therapeutic options in Brazil are responsible for the growth of the market. The Brazil cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by end user. Eurofarma, Cálamo Distribuidora, and Pfizer are the major players in the Brazil cardiovascular disease therapeutics market.
Brazil Artificial Intelligence (AI) in Healthcare Market Analysis
Brazil's Artificial Intelligence (AI) in Healthcare Market is projected to grow from $0.17 Bn in 2022 to $3.60 Bn by 2030, registering a CAGR of 46.22% during the forecast period of 2022-30. The market will be driven by the growing demand for healthcare services and the increasing availability of AI technologies. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Google Health, DASA & Inovacao AI.
Brazil Anti Aging Therapeutics Market Analysis
Brazil anti-aging therapeutics market is projected to grow from $15 Mn in 2022 to $55 Mn in 2030 with a CAGR of 17.53% for the year 2022-2030. The growing disposable income in Brazil and the rise in the geriatric population in Brazil are expected to drive the expansion of the market. The Brazil anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key competitors in the market are Signo Vinces, Plantus, and Betterhumans.
Brazil Biomaterials in Healthcare Market Analysis
The Brazil Biomaterials in Healthcare Market is expected to witness growth from $3.90 Bn in 2022 to $11.30 Bn in 2030 with a CAGR of 14.20% for the forecasted year 2022-2030. The increasing incidence of periodontal disease, tooth decay, oral cancer, halitosis, and dental caries in Brazil is driving demand for biomaterials, which is expected to propel growth in the Brazil biomaterial healthcare market. The market is segmented by type and by application. Some key players in this market include: Baumer SA, Injex Surgical Industries, FGM Products Odontologicos, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Brazil Healthcare Insurance Market Analysis
The Brazil healthcare insurance market is projected to grow from $50.66 Bn in 2022 to $98.01 Bn by 2030, registering a CAGR of 8.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing demand for private healthcare services, economic growth and rising income, regulatory reforms and technological advancements. The market is segmented by component, the provider, coverage, health insurance plans and by end-user. Some of the major players include Bradesco Saude, Amil International Medical Assistance, Hapvida Sistema, Porto Seguro and Allianz.
Brazil Healthcare Claims Management Market Analysis
The Brazil healthcare claims management market is projected to grow from $667.5 Mn in 2022 to $3828.37 Mn by 2030, registering a CAGR of 24.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased adoption of value-based care, increasing demand for healthcare services, government initiatives and rising healthcare costs. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include Bradesco Saude, Sinistro Facil, Amil, DXC Technology, Accenture and Cognizant.
Brazil ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Brazil's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to grow from $739 Mn in 2022 to $1,419 Mn in 2030 with a CAGR of 8,5% for the year 2022-30. The rising incidence of ADHD in Brazil and supportive government initiatives by the Brazilian government are responsible for the growth of the market. The Brazil ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Some of the key players in the market include Corporacion Bonima, Ovidio J. Vides, and Eli Lily.
Brazil Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil Liver Disease Therapeutics market will reach a value of $970 Mn from $577 Mn in 2022, growing at a CAGR of 6.7% during 2022-2030. Liver Disease Therapeutics in Brazil is dominated by domestic pharmaceutical companies such as Eurofarma, Aché Laboratórios, and EMS. The Liver Disease Therapeutics market in Brazil is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Brazil Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Brazil Oncology Clinical Trials Market Analysis
Brazil's oncology clinical trials market is projected to grow from $316.3 Mn in 2022 to $523.4 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022-30. The market will be driven by the increased investment in healthcare and research and the rise in oncology clinical trials owing to rising cancer cases in Brazil. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Eurofarma Laboratórios S.A.
Brazil Oral Care Market Analysis
The Brazil Oral Care market was valued at $881 Mn in 2022 and is estimated to expand at a CAGR of 7.2% from 2022 to 2030 and will reach $1536 Mn in 2030. One of the main reasons propelling the growth of this market is Technological advancements, Increasing disposable income. The market is segmented by type, drug and distribution channel. Some key players in this market are Fresh Up Italia, The Procter & Gamble Company, Fresh, Condor Sa, Colgate-Palmolive, Johnson & Johnson, Dentek Oral Care, Hypermarcas, Acryline, GlaxoSmithKline Prestige Brands among others.
Brazil Multiple Myeloma Therapeutics Market Analysis
The Brazil Multiple Myeloma Therapeutics Market was valued at $209 Mn in 2022 and is estimated to expand at a CAGR of 5.5% from 2022 to 2030 and will reach $320 Mn in 2030. Brazil One of the main reasons propelling the growth of this Market is Advancements in diagnostic and treatment technologies, aging population. The Market is segmented by type, drug and distribution channel. Some key players in this Market are Ache Laboratories Pharmaceutics, Eurofarma Laboratories, Biolab Sanus Pharmaceutical, Libbs Pharmaceutical, Cristalia Products Químicos Pharmaceuticals, Blau Pharmaceutical, Sanofi, EMS, Hypermarcas and others.
Brazil Diabetes Drugs Market Analysis
The Brazil diabetes drugs market size was valued at $1.54 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.1% from 2022 to 2030 and will reach $2.67 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The Brazil diabetes drug market will grow because the growing aging population, as the population ages, the incidence of diabetes is expected to increase, creating a greater demand for diabetes drugs. The key market players are Ache Laboratorios Farmaceuticos (BRA), Biolab Sanus Farmaceutica (BRA), Cristália Produtos Químicos (BRA), EMS Sigma Pharma (BRA)Boehringer Ingelheim, and others.
Brazil Connected Healthcare Market Analysis
The Brazil-connected healthcare market is projected to grow from $1.66 Bn in 2022 to $13.04 Bn by 2030, registering a CAGR of 29.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be the growing demand for healthcare services, technological innovations, government initiatives and the ageing population. The market is segmented by type, function and by application. Some of the major players include Dr.Consulta, Grupo Fleury, Pixeon, Siemens Healthineers, GE Healthcare and Medtronic.
Brazil Artificial Intelligence (AI) in Medical Imaging Market Analysis
Brazil artificial intelligence (AI) in medical Imaging market size was valued at $38 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.4% from 2022 to 2030 and will reach $449 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the Brazil Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market inclue, Vitta (BRA), Hi Technologies (BRA), Brain4care (BRA), TissueLabs (BRA), Ninsaúde (BRA), Docway (BRA), Medcloud (BRA), Fiplex, Epistemic, BoaConsulta, GE Healthcare, Philips Healthcare, Siemens Healthineers,, IBM Watson Health, NVIDIA Corporation, and others.
Brazil Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Brazil Primary Hyperoxaluria (PH) Therapeutics Market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 5.8% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is the development of new therapies, and rising healthcare spending. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market are Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Allena Pharmaceuticals, and Theralogics, among others.
Brazil Neurology Clinical Trials Market Analysis
The Brazil Neurology Clinical Trials market is projected to grow from $130.8 Mn in 2022 to $216.4 Mn by 2030, registering a CAGR of 6.5% during the forecast period of 2022 - 2030. The market will be driven by the high prevalence of neurological disorders and government initiatives to support clinical research in the country. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Biogen Inc & Aché Laboratórios Farmacêuticos S.A.
Brazil 3D Printing Medical Devices Market Analysis
The Brazil 3D Printing Medical Devices market size was valued at $74 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.3% from 2022 to 2030 and will reach $ 266 Mn in 2030. The market is segmented by component, application, technology, and end user. The Brazil 3D Printing Medical Devices market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Timpel Medical, Aditus Medical, BioArchitects, Z3DLab, Axial 3D, 3D Biotech, BioArchitects Brazil, MediArchitects, Stratasys, Materialise, GE Additive, and others.
Brazil Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The Brazil COPD Therapeutics Market was valued at $456 Mn in 2022 and is estimated to expand at a CAGR of 8.1% from 2022 to 2030 and will reach $851 Mn in 2030. One of the main reasons propelling the growth of this market is urbanization, aging population. The market is segmented by Drug class and By distribution channel. Some key players in this market are Aché Laboratories, Cristália Products Químicos Pharmaceutics, Eurofarma Laboratories, Laboratórios Teuto Brasileiro, EMS Sigma Pharma, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Brazil Limited and others.
Brazil Teleradiology Market Analysis
The Brazil Teleradiology market size was valued at $59 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 12.7% from 2022 to 2030 and will reach $ 154 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Brazil teleradiology market will grow due to Increasing demand for remote radiology services. The key market players are Telelaudo, Imex Medical Group, CMB Diagnósticos, Telemedicina Brasil, Medcloud, Telerrad, ONRAD, Telerradiologia do Brasil, Smart, Teleradiologia, Clínica Radiológica da Mulher.and others.
Brazil Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Brazil infectious disease therapeutics market will reach a value of $4.5 Bn from $3.1 Bn in 2022, growing at a CAGR of 5.4% during 2022-2030. Infectious Disease Therapeutics in Brazil is dominated by a few domestic pharmaceutical companies such as Cristália, Fiocruz and Eurofarma. The Infectious Disease Therapeutics market in Brazil is segmented into different therapeutic areas and different diseases type. The major factors affecting the Brazil infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various areas of Brazil.
Brazil Clinical Diagnostics Market Analysis
Brazil's clinical diagnostic market was valued at $1.7 Bn in 2022 and is estimated to expand at a CAGR of 7% from 2022-30 and will reach $2.9 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Diagnósticos da América S.A. (DASA), Quest Diagnostics Incorporated, Synlab Solutions in Diagnostics, Grupo Fleury, Hospital Israelita Albert Einstein, Alliar, Boris Berenstein Diagnostic Center, Clinica da Imagem do Tocantis, Abramed, Hermes Pardini Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Roche, and others.
Brazil Rheumatology Drugs Market Analysis
Brazil's rheumatology drugs market is projected to grow from $1.526 Bn in 2022 to $2.057 Bn by 2030, registering a CAGR of 3.80% during the forecast period of 2022-2030. The prevalence of rheumatic diseases, such as osteoarthritis, rheumatoid arthritis, and lupus, is high in Brazil, which drives the demand for rheumatology drugs. According to a study by the Brazilian Society of Rheumatology, around 30 million Brazilians suffer from some type of rheumatic disease. Aché is one of the largest pharmaceutical companies in Brazil, with a focus on research and development of innovative drugs. The company has a strong presence in the rheumatology drugs market, with products such as Artrinovo and Artril.
Brazil Neurology Devices Market Analysis
Brazil's Neurology Device Market size is at around $316 Mn in 2022 and is projected to reach $619 Mn in 2030, exhibiting a CAGR of 8.8% during the forecast period. Brazil has a high incidence of neurological disorders such as epilepsy, Parkinson's disease, and migraine, which is driving demand for neurology devices that is captured by both local and international players like Neuroservice, Neurosoft, NeuroRx, Medtronic, and Boston Scientific. This report by Insights10 is segmented by product type like neurostimulation, interventional neurology, neurosurgery devices, and neuro-endoscopes, and by the end user.